期刊文献+

血清MMP-3、TIMP-1及HC gp-39在早期RA患者的表达与临床的相关性研究 被引量:3

Study on the Correlationship Between Serum Levels of MMP-3,TIMP-1,HC gp-39 and Clinical Activity in Patients with Early Rheumatoid Arthritis
下载PDF
导出
摘要 目的:研究血清基质金属蛋白酶-3(matrix metalloproteinase 3,MMP-3)、金属蛋白酶组织抑制剂-1(tissue inhibitors of metalloproteinase 1,TIMP-1)及人类软骨糖蛋白-39(human cartilage glycoprotein 39,HC gp-39)在早期类风湿关节炎(rheumatoid arthritis,RA)患者的表达及其相关性因素,探讨其在早期RA的可能意义。方法:选取45例病程<1年的早期RA患者和32例健康查体者,采用酶联免疫吸附试验(ELISA)分别测定血清MMP-3、TIMP-1及HC gp-39水平,同时测定关节肿胀数(SJC)、关节压痛数(TJC)、血沉(ESR)、C反应蛋白(CRP)、类风湿因子(RF)等相关实验室指标。结果:早期RA患者血清MMP-3、TIMP-1及HC gp-39水平明显高于正常对照组(P<0.01)。不同X线分期各指标差异有统计学意义(P<0.05)。不同关节功能分级时各指标差异无统计学意义(P>0.05)。三指标与SJC(P<0.01)、TJC(P<0.01)、ESR(P<0.01)、CRP(P<0.01)呈正相关,与年龄、病程、晨僵时间、RF无明显相关(P>0.05)。结论:MMP-3、TIMP-1及HC gp-39在早期RA患者血清中呈高水平表达,可作为反映疾病活动和早期RA患者出现骨侵蚀的有益预测指标。 Objective To investigate how the changes of serum levels of the matrix metalloproteinase 3(MMP-3),tissue inhibitors of metalloproteinase 1(TIMP-1) and human cartilage glycoprotein 39(HC gp-39) might reflect the clinical activity and radiological damage in patients with early rheumatoid arthritis(RA).Methods The serum levels of MMP-3,TIMP-1 and HC gp-39 were measured with ELISA in 45 patients with early RA and 32 controls.Results Significantly increased serum levels of MMP-3,TIMP-1 and HC gp-39 were found in early RA patients as compared with those in controls(P〈0.01).The serun levels of MMP-3,TIMP-1 and HC gp-39 were positively correlated with the X-ray stage,SJC,TJC,ESR and CRP level(P〈0.05),but not with age,the disease course,length of morning stiffness,stage of function and RF level(P〉0.05).Conclusion Serum MMP-3,TIMP-1 and HC gp-39 levels increased significantly in early RA patients and might be used as indicators for disease activity and progress of bone erosion.
出处 《放射免疫学杂志》 CAS 2009年第5期508-511,共4页 Journal of Radioimmanology
关键词 早期 关节炎 类风湿 基质金属蛋白酶-3 金属蛋白酶组织抑制剂-1 人类软骨糖蛋白-39 early arthritis rheumatoid matrix metalloproteinase 3 tissue inhibitors of metalloproteinase 1 human cartilage glycoprotein 39
  • 相关文献

参考文献12

  • 1Arnett FC, Edworthy SM, Block DA, et al. The ARA 1987 revised criteria for the classification of rheumatoid arthritis[ J]. Arthritis Rheum, 1988,31:315-324.
  • 2Reboul P, Pelerier JP, Tardif G, et al. The new eollagenase,collagenase-3 ,is expressed and synthesized by human chondrocytes but not by synoviocytes:a role in the osteoarthritis[ J]. J Ciin Invest,1996,97:2011- 2019.
  • 3Xie DL, Hui F, Meyers R, et al. Cartilage chondrolysis by fibrenectin fragments is associated with release of several proteinases:stromelysin plays a major role in chondrolysis[ J]. Arch Biochem Biophys ,1994,311 : 205-212.
  • 4Kleiner DE Jr, Tuuttila A, Tryggvason K, et al. Stability analysis of latent and active 72-kDa type Ⅳ ollagenase : the role of tissue inhibitor of mtalloproteinases-2 (TIMP-2) [ J ]. Biochemistry, 1993,32 (6) : 1583.
  • 5Myem A, Lakey R,Cawston,TE, et al. Serum MMP-1 and TIMP-1 levels are increased in patients with psoriatic arthritis and their siblings [ J]. Rheumatology( Oxford), 2003,42:83-88.
  • 6Hakala BE, White C, Recldies AD. Human cartilage gp-39, a major secretary product of articular chondrocytes and synovial cells ,ia a mammalian member of a chitinase protein family[ J]. J Biol Chem, 1993,268 : 25803-25810.
  • 7Volck B, Price PA, Johansen JS, et al. YKL-40, a mammalian member of the chitinase family, is a matrix protein of specific granules in human neutrophils [ J ]. Proc Assoc Am Physicians, 1998,110 : 315-360.
  • 8Johansen JS, Jensen HS, Price PA. A new biochemical marker for joint injury:analysis of YKL-40 in serum and synovial fluid[J]. Br J Rheumatol, 1993,32 : 949 -955.
  • 9Vos K, Steenbakkers P, Miltenburg AM, et al. Raised human cartilage glycoprotein-39 plasma levels in patients with rheumatoid arthritis and other inflammatory conditions[ J]. Ann Rheum Dis, 2000,59:544-548.
  • 10王晓霞,李小峰,王来远,胡学芳,张琳,李雪飞.类风湿关节炎血清基质金属蛋白酶-3水平及其影响因素的探讨[J].中华风湿病学杂志,2004,8(1):16-19. 被引量:32

二级参考文献25

  • 1Klimiuk PA,Sierakowski S,Latosiewicz R,et al.Serum matrix metalloproteinases and tissue inhibitors of metalloproteinases in different histologieal variants of rheumatoid synovitis. Rheumatology (Oxford),2002,41:78-87.
  • 2Yamanaka H,Matsuda Y,Tanaka M,et al. Serum matrix metalloproteinase 3 as a predictor of the degree of joint destruction during the six months after measurement,in patients with early rheumatoid arthritis. Arthritis Rheum,2000,43:852-858.
  • 3Cunnane G,Fitz-Gerald O,Beeton C,et al. Early joint erosions and serum levels of matrix metalloproteinases 1,matrix metalloproteinases 3,and tissue inhibitor of metalloproteinases 1 in rheumatoid athritis.Arthritis Rheum,2001,44:2263 -2274.
  • 4Ishiguro N,Ito T,Obata K,et al. Determination of stromelysin-1,72 Kda type Ⅳ collagenase, tissue inhibitor of metalloproteinase-1 (TIMP-1),and TIMP-2 in synovial fluid and serum from patients with rheumatoidarthritis .J Rheumatol, 1996,23:1599-1604.
  • 5Wolfe F,Sharp JT.Radiographic outcome of recent-onset rheumatoid arthritis:a 19-year study of radiographic progression.Arthritis Rheum,1998,41:1571-1582.
  • 6Green MJ,Gough AK,Devlin J,et al. Serum MMP-3 and MMP-1 and progression of joint damage in early rheumatoid arthritis. Rheumatology,2003,42:83-88.
  • 7Posthumus,MD,Limburg PC,Westra J. Serum matrix metalloproteinase 3in early rheumatoid arthritis is correlated with disease activity and radiological progression. J Rheumatol,2000,27:2761-2768.
  • 8Ribbens C,Andre B,Jaspar J.Matrix mettalloproteinase-3 serum levels are correlated with disease activity and predict clinical response in rheumatoid arthritis.J Rheumatol,2000,27:888-893.
  • 9Zucker S,Hymovitz M,Conner C,et al. Measurement of matrix metalloproteinases and tissue inhibitors of metalloproteinases in blood and tis-sues:clinical experimental applications.Ann NY Acad Sci, 1999,878:212-227.
  • 10Okada Y.Proteinases and matrix degradation. In:Kelley WN,Ruddy S,Harris ED,eds.Textbook of rheumatology.6th ed. Philadelphia:WB Saunders,2000.55-72.

共引文献38

同被引文献30

  • 1梁柳琴,许韩师,杨岫岩,叶玉津,詹钟平,陈伟玲.类风湿关节炎血清基质金属蛋白酶-3检测及其临床意义[J].中山大学学报(医学科学版),2004,25(B06):128-131. 被引量:10
  • 2许荣,钟丽民,袁斌,周丽萍,何东林,候娜莉,李宁丽,王利,陈广洁,余奇文,张冬青.骨桥蛋白介导类风湿关节炎发病机制的初步研究[J].中华风湿病学杂志,2006,10(5):261-264. 被引量:13
  • 3吴庆军,曾小峰,唐福林,张奉春,董怡,赵岩,田新平,史艳萍,张乃峥.类风湿关节炎早期诊断的血清学研究和临床应用[J].医学研究杂志,2006,35(5):43-44. 被引量:27
  • 4刘琼,李向培.骨桥蛋白在类风湿关节炎发病机制中的作用[J].中华风湿病学杂志,2007,11(2):109-111. 被引量:5
  • 5Maseri A. Inflammation, atherosclerosis, and ischemic events exploring the hidden side of the moon [ J ]. N Engl J Med , 1997,336:1014-1016.
  • 6Amett FC, Edworthy SM, Bloch DA, et al. The American rheumatism association 1987 revised criteria for the classification of rheumatoid arthritis[J]. Arthritis Rheum,1988,31:315-324.
  • 7Kohno K, Kurimoto M. Molecule of the month interleukin-18, a cytokine which resembles IL-1 structurally and IL-12 functionally but exerts its effect independently of both [ J ]. Clin Immunol Immunopath, 1998,86 (1) :11-15.
  • 8Parnet P,Garka KE,Bonnert TP,et al. IL-1 RrP is a novel receptor-like molecule similar to the type Ⅰ interleukin-1 receptor and its homologues T1/ST2 and IL-1R ACP [ J ]. J Bil Chem, 1996, 271 ( 8 ) : 3967-3970.
  • 9Xie DL,Hui F,Meyem R,et al. Cartilage chondrolysis by fibronectin fragments is associated with release of several proteinases : stromelysin plays a major role in chondrolysis[ J ]. Arch Biochem Biophys, 1994,311 (2) :205-212.
  • 10Machold KP, Stamm TA, Nell VP, et al. Very recent onset rheu- matoid arthritis:clinical and serological patient characteristics as- sociated with radiographic progression over the first years of dis- ease. Rheumatology ( Oxford), 2007,46 ( 2 ) : 329 -342.

引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部